The Business Research Company’s 2026 market reports include new capabilities such as market attractiveness scoring and analysis, total addressable market analysis, company scoring matrix, interactive excel data dashboard, improved supply chain analysis, upcoming startups in the market, and overview of key products, aimed at improving the depth, usability, and strategic value of the insights delivered.
How Will The Market Size Of The Cell-Free DNA (cfDNA) Blood Collection Tube Market Evolve From 2026 To 2030?
The market size for cell-free DNA (cfDNA) blood collection tubes has seen rapid expansion in recent years. This market is expected to increase from $1.33 billion in 2025 to $1.51 billion in 2026, registering a compound annual growth rate (CAGR) of 13.6%. The historical growth of this market can be attributed to the rising demand for prenatal testing, the growth in cancer diagnostics, the increasing adoption of cfDNA in research, rising laboratory automation, and the expansion of diagnostic centers.
The market for cell-free DNA (cfDNA) blood collection tubes is anticipated to experience substantial expansion over the upcoming years. This market is projected to reach $2.49 billion by 2030, exhibiting a compound annual growth rate (CAGR) of 13.3%. This projected increase can be attributed to several factors, including advancements in blood tube preservatives, the incorporation of AI diagnostics, the expanding liquid biopsy market, an increase in clinical trials, and surging demand within developing markets. Key developments expected during this forecast period encompass improved sample preservation techniques, seamless integration with liquid biopsy platforms, the establishment of standardized blood collection procedures, increased automation in sample handling, and the introduction of highly stable tube designs.
Download the Free Sample Report to Explore Key Market Insights:
https://www.thebusinessresearchcompany.com/sample.aspx?id=28160&type=smp
What Drivers Are Influencing The Cell-Free DNA (cfDNA) Blood Collection Tube Market?
The market for cell-free DNA (cfDNA) blood collection tubes is anticipated to grow in the future due to the rising occurrence of respiratory disorders. These conditions, which impair efficient breathing and oxygen delivery, are frequently exacerbated by air pollution, leading to an increased risk of ailments such as asthma, bronchitis, and chronic obstructive pulmonary disease (COPD). Cell-free DNA (cfDNA) blood collection tubes offer a non-invasive method for managing respiratory disorders by enabling the detection of genetic mutations, monitoring disease progression, and evaluating treatment responses via a straightforward blood test, thus minimizing the need for invasive lung biopsies. For example, in December 2024, the Centers for Disease Control and Prevention, a US-based government agency, reported that an estimated 17,000 to 34,000 hospitalizations were attributed to respiratory syncytial virus (RSV) between October 1 and November 30, 2024. Consequently, the growing incidence of respiratory disorders is a key factor driving the expansion of the cell-free DNA (cfDNA) blood collection tube market. A surge in cancer cases, propelled by rising unhealthy lifestyle habits, is expected to fuel the growth of the cell-free DNA (cfDNA) blood collection tube market. The increasing prevalence of cancer is linked to factors such as inadequate diet, smoking, and insufficient physical activity. Cell-free DNA (cfDNA) blood collection tubes are crucial in cancer management, facilitating liquid biopsies that allow for the identification of tumor-specific genetic mutations, tracking of disease progression, evaluation of treatment effectiveness, and detection of resistance mutations through a straightforward blood test, thereby diminishing the need for intrusive tissue biopsies. For example, in May 2024, the National Cancer Institute, a US-based government agency, projected that the population of cancer survivors in the United States will rise to 26 million by 2040, up from 18.1 million in 2022. Thus, the escalating incidence of cancer is a significant driver for the cell-free DNA (cfDNA) blood collection tube market.
Which Segment Areas Are Covered In The Cell-Free DNA (cfDNA) Blood Collection Tube Market Analysis?
The cell-free dna (cfdna) blood collection tube market covered in this report is segmented –
1) By Type: 5ml, 10ml
2) By Sample Type: Plasma, Serum, Whole Blood
3) By Application: In Vitro Diagnostics, Scientific Research
4) By End-User: Diagnostic Laboratories, Hospitals Or Clinical Centers, Genetic Diagnostic Labs, Cancer Research Centers, Research And Development Institutions, Conventional Diagnostic Centers
Subsegments:
1) By 5 mL: Single Use Tube, Vacuum Blood Collection Tube, Gel Separator Tube
2) By 10 mL: Double Draw Tube, High Volume Collection Tube, Anticoagulant Treated Tube
What Key Developments And Trends Are Impacting The Cell-Free DNA (cfDNA) Blood Collection Tube Market?
Leading organizations within the cell-free DNA (cfDNA) blood collection tube market are prioritizing the automation of cfDNA extraction to improve workflow effectiveness. This automation involves the deployment of sophisticated robotic instruments and consistent protocols for isolating cell-free DNA from blood samples, requiring minimal human input. This approach enhances efficiency, precision, and uniformity, while simultaneously decreasing processing time and the potential for human error. For example, in September 2023, Yourgene Health plc, a UK-based molecular diagnostics company, introduced the MagBench Automated DNA Extraction Instrument and Kit. This offering presents a swift, uncomplicated, and economical bench-top robotic solution, specifically designed for cell-free DNA extraction in non-invasive prenatal testing (NIPT) workflows. The purpose of this release is to reinforce automation in NIPT workflows by providing superior throughput, consistency, and dependability in cfDNA extraction, concurrently reducing manual effort and operational expenditures.
Which Global Companies Are Actively Competing In The Cell-Free DNA (cfDNA) Blood Collection Tube Market?
Major companies operating in the cell-free dna (cfdna) blood collection tube market are Roche Holding AG, Thermo Fisher Scientific Inc., Becton Dickinson (BD), Qiagen N.V., SARSTEDT AG & Co. KG, Guangzhou Improve Medical Technology, Streck Inc., DiaCarta Inc., Zymo Research Corporation, Biomatrica Inc., PreAnalytiX GmbH, Beijing Cowin Bioscience Co.Ltd., Norgen Biotek Corporation, Nonacus Limited, Guangdong Ardent Biomed Co. Ltd, MagBio Genomics Inc., VanGenes, BEAVER, Hebei Xinle Science & Technology Co. Ltd., Nasmed Diagnostics Pvt. Ltd.
Read the full cell-free dna (cfdna) blood collection tube market report here:
Which Regions Are Expected To Experience Rapid Expansion In The Cell-Free DNA (cfDNA) Blood Collection Tube Market?
North America was the largest region in the cell-free DNA (cfDNA) blood collection tube market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the cell-free dna (cfdna) blood collection tube market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
Request A Tailored Cell-Free DNA (cfDNA) Blood Collection Tube Market Research Report For Competitive Advantage:
https://www.thebusinessresearchcompany.com/customise?id=28160&type=smp
Browse Through More Reports Similar to the Global Cell-Free DNA (cfDNA) Blood Collection Tube Market 2026, By The Business Research Company
Medical Skin Markers Market Report 2026
https://www.thebusinessresearchcompany.com/report/medical-skin-markers-global-market-report
Surface Vision And Inspection Market Report 2026
https://www.thebusinessresearchcompany.com/report/surface-vision-and-inspection-global-market-report
Biomarkers Market Report 2026
https://www.thebusinessresearchcompany.com/report/biomarkers-global-market-report
Get in touch with us:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas +1 310-496-7795
Asia +44 7882 955267 & +91 8897263534
Europe +44 7882 955267
Email us at info@tbrc.info
Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model